BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1716205)

  • 21. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
    Le Contel C; Temime N; Charron DJ; Parant MA
    J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
    Zanetti G; Heumann D; Gérain J; Kohler J; Abbet P; Barras C; Lucas R; Glauser MP; Baumgartner JD
    J Immunol; 1992 Mar; 148(6):1890-7. PubMed ID: 1541827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of tumor necrosis factor-alpha gene expression. Desensitization of prostaglandin E2-induced suppression.
    Spengler RN; Spengler ML; Strieter RM; Remick DG; Larrick JW; Kunkel SL
    J Immunol; 1989 Jun; 142(12):4346-50. PubMed ID: 2723432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial endotoxin regulation of cytokine receptors on murine bone marrow cells: in vivo and in vitro study.
    Shieh JH; Peterson RH; Moore MA
    J Immunol; 1994 Jan; 152(2):859-66. PubMed ID: 8283056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of antimicrobial peptides derived from the beetle Allomyrina dichotoma defensin on endotoxic shock in mice.
    Koyama Y; Motobu M; Hikosaka K; Yamada M; Nakamura K; Saido-Sakanaka H; Asaoka A; Yamakawa M; Sekikawa K; Kitani H; Shimura K; Nakai Y; Hirota Y
    Int Immunopharmacol; 2006 Feb; 6(2):234-40. PubMed ID: 16399628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice.
    Chorinchath BB; Kong LY; Mao L; McCallum RE
    J Immunol; 1996 Feb; 156(4):1525-30. PubMed ID: 8568256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation.
    Li CH; Wang JH; Redmond HP
    J Leukoc Biol; 2006 Apr; 79(4):867-75. PubMed ID: 16461741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1beta induces in vivo tolerance to lipopolysaccharide in mice.
    Alves-Rosa F; Vulcano M; Beigier-Bompadre M; Fernández G; Palermo M; Isturiz MA
    Clin Exp Immunol; 2002 May; 128(2):221-8. PubMed ID: 12041508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram.
    Pettipher ER; Labasi JM; Salter ED; Stam EJ; Cheng JB; Griffiths RJ
    Br J Pharmacol; 1996 Apr; 117(7):1530-4. PubMed ID: 8730750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective tolerance to the toxic and metabolic effects of interleukin 1.
    Mengozzi M; Ghezzi P
    Endocrinology; 1991 Mar; 128(3):1668-72. PubMed ID: 1999179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indirect and selective down-regulation of serum tumor necrosis factor-alpha release by interleukin-1 beta.
    le Contel C; Parant F; Parant M
    Immunobiology; 1992 Nov; 186(3-4):199-213. PubMed ID: 1490727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multistep regulation mechanisms for tolerance induction to lipopolysaccharide lethality in the tumor-necrosis-factor-alpha-mediated pathway. Application of non-toxic monosaccharide lipid A analogues for elucidation of mechanisms.
    Matsuura M; Kiso M; Hasegawa A; Nakano M
    Eur J Biochem; 1994 Apr; 221(1):335-41. PubMed ID: 8168521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression reprogramming protects macrophage from septic-induced cell death.
    Melo ES; Barbeiro DF; Gorjão R; Rios EC; Vasconcelos D; Velasco IT; Szabo C; Curi R; de Lima-Salgado TM; Soriano FG
    Mol Immunol; 2010 Oct; 47(16):2587-93. PubMed ID: 20728938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of production of tumor necrosis factor by monoclonal antibodies to lipopolysaccharides.
    Vacheron F; Mandine E; Lenaour R; Smets P; Zalisz R; Guenounou M
    J Infect Dis; 1992 May; 165(5):873-8. PubMed ID: 1569336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid regulation of hepatic TNF production following cecal ligation and puncture sepsis.
    Zawacki JK; Hunt JL; Gamelli RL; Filkins JP
    Shock; 1997 Aug; 8(2):141-5. PubMed ID: 9261906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of serum tumor necrosis factor in glucocorticoid-sensitive and -resistant rodent endotoxin shock models.
    Zuckerman SH; Bendele AM
    Infect Immun; 1989 Oct; 57(10):3009-13. PubMed ID: 2777371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effect of glucocorticoids on tumour necrosis factor production in mice: up-regulation by early pretreatment with dexamethasone.
    Fantuzzi G; Demitri MT; Ghezzi P
    Clin Exp Immunol; 1994 Apr; 96(1):166-9. PubMed ID: 8149662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock.
    Gadina M; Bertini R; Mengozzi M; Zandalasini M; Mantovani A; Ghezzi P
    J Exp Med; 1991 Jun; 173(6):1305-10. PubMed ID: 2033366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo Lipopolysaccharide Tolerance Recruits CD11b+ Macrophages to the Liver with Enhanced Bactericidal Activity and Low Tumor Necrosis Factor-Releasing Capability, Resulting in Drastic Resistance to Lethal Septicemia.
    Kinoshita M; Miyazaki H; Nakashima H; Nakashima M; Nishikawa M; Ishikiriyama T; Kato S; Iwaya K; Hiroi S; Shinomiya N; Seki S
    J Innate Immun; 2017; 9(5):493-510. PubMed ID: 28675904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha.
    Butler LD; Layman NK; Riedl PE; Cain RL; Shellhaas J; Evans GF; Zuckerman SH
    J Neuroimmunol; 1989 Sep; 24(1-2):143-53. PubMed ID: 2681261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.